Moomoo AIのまとめ
SeaStar Medical Holding Corporation, a medical technology company, has announced a registered direct offering of 947,868 shares of its common stock at a price of $10.55 per share. The offering is accompanied by a concurrent private placement of unregistered common stock purchase warrants, exercisable at $10.55, immediately upon issuance and expiring five years from the date of issuance. The purchase price for each share of common stock is also set at $10.55. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering, which is expected to close on or about July 11, 2024, subject to customary closing conditions. The proceeds, before expenses, are estimated to be approximately $9.3 million and are intended for the redemption and repayment of certain notes, as well as funding the company's development and commercialization activities and general corporate purposes. This offering follows SeaStar Medical's recent compliance with Nasdaq's minimum market value requirement and its ongoing efforts to maintain its listing on the exchange.
SeaStar Medical Holding Corporation, a medical technology company, has announced a registered direct offering of 947,868 shares of its common stock at a price of $10.55 per share. The offering is accompanied by a concurrent private placement of unregistered common stock purchase warrants, exercisable at $10.55, immediately upon issuance and expiring five years from the date of issuance. The purchase price for each share of common stock is also set at $10.55. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering, which is expected to close on or about July 11, 2024, subject to customary closing conditions. The proceeds, before expenses, are estimated to be approximately $9.3 million and are intended for the redemption and repayment of certain notes, as well as funding the company's development and commercialization activities and general corporate purposes. This offering follows SeaStar Medical's recent compliance with Nasdaq's minimum market value requirement and its ongoing efforts to maintain its listing on the exchange.
医療テクノロジー企業であるSeaStar Medical Holding Corporationは、普通株式947,868株を1株あたり10.55ドルで登録直接公募することを発表しました。公募には、非公募の普通株式購入オプション付きの同時承認済みの非公募発行が添付されており、オプションは発行直後に10.55ドルで行使でき、発行日から5年後に満期となります。1株あたりの買付価格も10.55ドルで設定されています。H.C. Wainwright＆Co.が公募の排他的な販売代理店を務め、通常のクロージング条件に従って、2024年7月11日前後に終了する予定です。手数料を除いて、収益は約930万ドルと...すべて展開
医療テクノロジー企業であるSeaStar Medical Holding Corporationは、普通株式947,868株を1株あたり10.55ドルで登録直接公募することを発表しました。公募には、非公募の普通株式購入オプション付きの同時承認済みの非公募発行が添付されており、オプションは発行直後に10.55ドルで行使でき、発行日から5年後に満期となります。1株あたりの買付価格も10.55ドルで設定されています。H.C. Wainwright＆Co.が公募の排他的な販売代理店を務め、通常のクロージング条件に従って、2024年7月11日前後に終了する予定です。手数料を除いて、収益は約930万ドルと見積もられており、特定のノートの償還および返済、同社の開発および商品化活動、一般的な企業目的の資金調達に充てられます。この公募は、SeaStar Medicalがナスダックの最低市場価値要件に準拠したことと、取引所に上場し続けるための取り組みの一環として行われました。
役に立った
役に立たない